biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Always Late For The Game!

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Oct 30, 2022 1:43am

132 Views

Post# 35058279

RE:Always Late For The Game!

I didn't say it was Monday, beenthere. The Ontario Securities Commission (OSC), the British Columbria Securities Commission (BCSC) and all the other little securities commissions said it was Monday.

Quod erat demonstrandum. beenthere.

I think you ought to tell the securities commissions that they had best sync their calendars with poof's, he being your own personal authority on these matters.

jd

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario